Lifetime ovulatory years and ovarian cancer gene expression profiles

Abstract

Background Greater ovulatory years is associated with increased ovarian cancer risk. Although ovulation leads to an acute pro-inflammatory local environment, how long-term exposure to ovulation impacts ovarian carcinogenesis is not fully understood. Thus, we examined the association between gene expression profiles of ovarian tumors and lifetime ovulatory years to enhance understanding of associated biological pathways. Methods RNA sequencing data was generated on 234 invasive ovarian cancer tumors that were high-grade serous, poorly differentiated, or high-grade endometrioid from the Nurses’ Health Study (NHS), NHSII, and the New England Case Control Study. We used linear regression to identify differentially expressed genes by estimated ovulatory years, adjusted for birth decade and cohort, overall and stratified by menopausal status at diagnosis. We used false discovery rates (FDR) to account for multiple testing. Gene set enrichment analysis (GSEA) with Cancer Hallmarks, KEGG, and Reactome databases was used to identify biological pathways associated with ovulatory years. Results No individual genes were significantly differentially expressed by ovulatory years (FDR > 0.19). However, GSEA identified several pathways that were significantly associated with ovulatory years, including downregulation of pathways related to inflammation and proliferation (FDR < 1.0 × 10–5). Greater ovulatory years were more strongly associated with downregulation of genes related to proliferation (e.g., E2F targets, FDR = 1.53 × 10–24; G2M checkpoints, FDR = 3.50 × 10–22) among premenopausal versus postmenopausal women at diagnosis. The association of greater ovulatory years with downregulation of genes involved in inflammatory response such as interferon gamma response pathways (FDR = 7.81 × 10–17) was stronger in postmenopausal women. Conclusions Our results provide novel insight into the biological pathways that link ovulatory years to ovarian carcinogenesis, which may lead to development of targeted prevention strategies for ovarian cancer.

Replication stress and defective checkpoints make fallopian tube epithelial cells putative drivers of high-grade serous ovarian cancer

“…Given the connection between ovulation and ovarian cancer 53 – 55 and considering the previously discussed evidence of increased replication stress in the fimbrial ends ( Figures 7A and 7B ), we next focused on exploring the possible correlation between menopausal status and 53BP1 staining levels in the fallopian tubes. To conduct this analysis, we performed 53BP1 staining on sections of the fimbrial ends obtained from premenopausal (pre-M) and post-menopausal (post-M) women, both with and without BRCA1 mutations ( Figure 7E ).…”

Identification of ULK1 as a novel mitophagy-related gene in diabetic nephropathy

“…In our study, the MRGs were obtained from the Reactome database, which is an emerging database and has been widely used in several studies (65)(66)(67)(68)(69). However, it did not include some mitophagy receptors such as BNIP3, p62, OPTN and so on.…”

Associations between prediagnostic aspirin use and ovarian tumor gene expression

“…For each case, treatment naïve primary FFPE ovarian tumor blocks were obtained and a 1.5 mm diameter tumor tissue core was isolated from tumor areas circled by the gynecologic pathologist. DNA and RNA were simultaneously extracted using the Qiagen All‐Prep RNA Isolation Kit as described 14 . In brief, we used the Illumina TruSeq™ RNA Exome Library Preparation Kit (Illumina Inc.) following the manufacturer's protocol to prepare the RNA‐sequencing (RNA‐Seq) libraries and sequenced on the multiple NextSeq 500 High‐output sequencing runs to target about 25 M pairs of 75‐base reads per sample.…”

“…All data were then transformed using voom . Using principal component analyses, we did not observed any batch or study effects 14 . Thus, we used pooled data from NHS, NHSII, and NECC.…”